English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/67203
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorEscobar-Díaz, Elisabeth-
dc.contributor.authorLópez-Martín, E.M.-
dc.contributor.authorHernández del Cerro, Mercedes-
dc.contributor.authorPuig-Kröger, Amaya-
dc.contributor.authorSoto-Cerrato, V.-
dc.contributor.authorMontaner, B.-
dc.contributor.authorGiralt, Ernest-
dc.contributor.authorGarcía-Marco, José A.-
dc.contributor.authorPérez-Tomás, R.-
dc.contributor.authorGarcía-Pardo, Angeles-
dc.date.accessioned2013-02-21T12:57:54Z-
dc.date.available2013-02-21T12:57:54Z-
dc.date.issued2005-04-
dc.identifier.citationLeukemia, 19 (4) : 572-579 (2005)es_ES
dc.identifier.issn0887-6924-
dc.identifier.urihttp://hdl.handle.net/10261/67203-
dc.description8 páginas, 5 figuras -- PAGS nros. 572-579es_ES
dc.description.abstractClinical treatment of B-cell chronic lymphocytic leukemia (B-CLL) is limited by the progressive drug resistance and nonselectivity of most drugs towards malignant cells. Depsipeptides are present in certain bacteria and display potent antitumor activity. We have studied the effect of the novel cyclodepsipeptide AT514 (serratamolide) from Serratia marcescens on B-CLL cell viability. AT514 induced apoptosis of B-CLL cells from the 21 patients studied, as confirmed by Annexin-V binding and nuclei condensation, with an average IC50 of 13 M. AT514 was effective in those B-CLL cases resistant to fludarabine, but had no effect on normal PBL. AT514 preferentially activated the intrinsic apoptotic pathway, as evidenced by loss of mitochondrial membrane potential, release of cytochrome c and activation of caspase-9 and -3, but not of caspase-8. Importantly, AT514 interfered with phosphatidylinositol-3 kinase and protein kinase C survival signals since it increased the apoptotic effect of LY294002 and BisI inhibitors, and induced Akt dephosphorylation at Ser 473. AT514 also decreased NF-B activity by dramatically reducing the levels of p65 in B-CLL. This was confirmed on functional assays using NF-B-luc-transfected Raji cells and transgenic mice. Our results establish that AT514 induces apoptosis of primary B-CLL cells and could be useful for clinical treatment of this malignancyes_ES
dc.description.sponsorshipThis work was supported by grants 08.3/0030.1/2003 from the Comunidad Autónoma de Madrid, SAF2003-00824 from the Ministerio de Ciencia y Tecnología (MCyT), and 01/1183 from Fondo de Investigación Sanitaria (to AGP); and CIDEM Grant 301888 (Generalitat de Catalunya)/Fundació Bosch i Gimpera, to RPT). E Escobar and E López-Martín were supported by fellowships from MCyTes_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Groupes_ES
dc.rightsclosedAccesses_ES
dc.subjectB-CLLes_ES
dc.subjectApoptosises_ES
dc.subjectdepsipeptidees_ES
dc.subjectcaspase activationes_ES
dc.subjectAkt/NF-B pathwayes_ES
dc.titleAT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells. Interference with the Akt/NF-kB survival pathwayes_ES
dc.typeartículoes_ES
dc.identifier.doihttp://dx.doi.org/10.1038/sj.leu.2403679-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://dx.doi.org/10.1038/sj.leu.2403679es_ES
dc.identifier.e-issn1476-5551-
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
restringido.pdf21,67 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.